Sangamo Therapeutics

In News

Analysts Expect Breakeven For Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Before Long - simplywall.st

simplywall.st - Jan 19, 2026

Sangamo Starts Putting BLA for Fabry Disease Gene Therapy Isa-Vec in Front of FDA - CGTLive®

CGTLive® - Dec 19, 2025

Sangamo Therapeutics' (SGMO) Buy Rating Reiterated at HC Wainwright - MarketBeat

MarketBeat - Feb 10, 2026

How the Narrative Surrounding Sangamo Therapeutics Is Shifting After New Regulatory and Valuation Signals - Yahoo Finance

Yahoo Finance - Dec 12, 2025

Eli Lilly to leverage Sangamo capsid technology for CNS disease therapies - MSN

MSN - Jan 19, 2026

Sangamo Therapeutics reports preliminary cash balance and CFO transition - Investing.com

Investing.com - Feb 03, 2026

Sangamo Therapeutics (SGMO) Price Target Increased by 17.31% to 3.89 - Nasdaq

Nasdaq - Feb 03, 2026

One-time Fabry gene therapy lifts kidney function in early trial data - Stock Titan

Stock Titan - Feb 03, 2026

Is Sangamo Therapeutics Inc. stock a hidden gem - 2025 Trading Recap & Consistent Profit Focused Trading Strategies - mfd.ru

mfd.ru - Feb 13, 2026

Sangamo Therapeutics Announces Pricing of $25.0 Million Underwritten Offering - Yahoo Finance

Yahoo Finance - Feb 03, 2026

FY2030 Earnings Forecast for SGMO Issued By HC Wainwright - MarketBeat

MarketBeat - Feb 11, 2026

Sangamo Therapeutics, Inc.'s (NASDAQ:SGMO) Share Price Boosted 29% But Its Business Prospects Need A Lift Too - simplywall.st

simplywall.st - Feb 03, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment